
Sign up to save your podcasts
Or


This week, we'll be placing a bet on a biotech stock that has previously featured in the $1000 challenge. We're hoping this investment will boost the challenge from its current $3,054 to $4,000, potentially achieving our second doubling.
While stocks like Root Inc [ROOT] and Incyte [INCY] show promise, the broader market direction remains the key question. Although media outlets generally predict an upward trend, Jim expresses skepticism in this week's "Trading Tips With Jim," explaining why it may not be so straightforward.
Tune in for this week's comprehensive stock market insights
By Jim Stromberg5
77 ratings
This week, we'll be placing a bet on a biotech stock that has previously featured in the $1000 challenge. We're hoping this investment will boost the challenge from its current $3,054 to $4,000, potentially achieving our second doubling.
While stocks like Root Inc [ROOT] and Incyte [INCY] show promise, the broader market direction remains the key question. Although media outlets generally predict an upward trend, Jim expresses skepticism in this week's "Trading Tips With Jim," explaining why it may not be so straightforward.
Tune in for this week's comprehensive stock market insights

3,223 Listeners

294 Listeners

8,991 Listeners

88 Listeners

762 Listeners

5 Listeners

3,093 Listeners

43 Listeners

59 Listeners

2,239 Listeners